Actively Recruiting
Study of CeraVe Moisturizing Cream for Maintaining Skin Hydration in Adults with Mild to Moderate Atopic Dermatitis
Led by Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse · Updated on 2025-10-02
98
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the effect of CeraVe emollient cream on restoring skin hydration in people with mild to moderate atopic dermatitis AD. This skin condition involves inflammation and problems with the skin barrier, including reduced ceramide production. The study aims to compare CeraVes ability to restore skin hydration with a commonly used pharmacy-made emollient and to assess differences in disease control scores between the two groups. Participants who have mild to moderate AD with significant improvement after steroid treatment will be randomly assigned to use either CeraVe or a standard emollient cream twice daily for 42 days. Both groups will use a basic detergent for washing. If a relapse occurs, participants should stop using the assigned emollient and seek medical evaluation, which will lead to withdrawal from the study. During the study, participants will be monitored over six weeks with scheduled visits to assess changes in eczema severity using the Eczema Area and Severity Index EASI score, cosmetic acceptability of the emollients, disease control tool scores, and skin appearance through photographs. Researchers will track relapse rates and other outcomes to evaluate the treatments effects on skin hydration and disease maintenance.
CONDITIONS
Brief Title
CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic Dermatitis
Research Team
P
Prof.ssa Elena Campione
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here